Overview
- Bristol Myers Squibb announced Wednesday a strategic agreement with Anthropic to deploy Claude across research, clinical development, manufacturing, commercial, and corporate teams.
- The company plans broad access for more than 30,000 employees so staff can use Claude’s reasoning and agent skills on day‑to‑day tasks.
- Early focus includes Claude Code to speed software work plus agents that draft clinical study reports, trace manufacturing root causes, and organize field insights for healthcare outreach.
- Claude will connect through secure integrations to scientific, clinical, regulatory, and commercial data with enterprise governance and audit controls in place.
- The plan builds on three years of AI investment and a multi‑vendor approach at BMS, with expected gains dependent on implementation, quality reviews, and compliance.